Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) Non Operating Income: 2016-2024

Historic Non Operating Income for Dianthus Therapeutics (DNTH) over the last 6 years, with Dec 2024 value amounting to $16.9 million.

  • Dianthus Therapeutics' Non Operating Income fell 25.45% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year decrease of 11.69%. This contributed to the annual value of $16.9 million for FY2024, which is 265.77% up from last year.
  • Per Dianthus Therapeutics' latest filing, its Non Operating Income stood at $16.9 million for FY2024, which was up 265.77% from $4.6 million recorded in FY2023.
  • In the past 5 years, Dianthus Therapeutics' Non Operating Income ranged from a high of $16.9 million in FY2024 and a low of $1.2 million during FY2022.
  • For the 3-year period, Dianthus Therapeutics' Non Operating Income averaged around $7.6 million, with its median value being $4.6 million (2023).
  • Data for Dianthus Therapeutics' Non Operating Income shows a peak YoY soared of 275.83% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Dianthus Therapeutics' Non Operating Income stood at $1.2 million in 2022, then skyrocketed by 275.83% to $4.6 million in 2023, then spiked by 265.77% to $16.9 million in 2024.